DE69519796D1 - PTPalpha-Bestimmung in der Tumordiagnose und -Prognose - Google Patents

PTPalpha-Bestimmung in der Tumordiagnose und -Prognose

Info

Publication number
DE69519796D1
DE69519796D1 DE69519796T DE69519796T DE69519796D1 DE 69519796 D1 DE69519796 D1 DE 69519796D1 DE 69519796 T DE69519796 T DE 69519796T DE 69519796 T DE69519796 T DE 69519796T DE 69519796 D1 DE69519796 D1 DE 69519796D1
Authority
DE
Germany
Prior art keywords
sample
alpha
pct
ptp
prognosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69519796T
Other languages
English (en)
Other versions
DE69519796T2 (de
Inventor
Karim Tabiti
Catherine J Pallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Molecular and Cell Biology
Original Assignee
Institute of Molecular and Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Molecular and Cell Biology filed Critical Institute of Molecular and Cell Biology
Application granted granted Critical
Publication of DE69519796D1 publication Critical patent/DE69519796D1/de
Publication of DE69519796T2 publication Critical patent/DE69519796T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69519796T 1994-06-10 1995-06-06 PTPalpha-Bestimmung in der Tumordiagnose und -Prognose Expired - Fee Related DE69519796T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411671A GB9411671D0 (en) 1994-06-10 1994-06-10 Tumor diagnosis and prognosis
PCT/EP1995/002166 WO1995034818A1 (en) 1994-06-10 1995-06-06 Tumor diagnosis and prognosis

Publications (2)

Publication Number Publication Date
DE69519796D1 true DE69519796D1 (de) 2001-02-08
DE69519796T2 DE69519796T2 (de) 2001-04-19

Family

ID=10756541

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69519796T Expired - Fee Related DE69519796T2 (de) 1994-06-10 1995-06-06 PTPalpha-Bestimmung in der Tumordiagnose und -Prognose

Country Status (7)

Country Link
US (1) US5888746A (de)
EP (1) EP0764272B1 (de)
AT (1) ATE198513T1 (de)
AU (1) AU2738195A (de)
DE (1) DE69519796T2 (de)
GB (1) GB9411671D0 (de)
WO (1) WO1995034818A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005646A1 (en) * 2002-03-26 2004-01-08 Beata Lecka-Czernik Use of the S2-6 gene product as a diagnostic marker for cancer detection
US20040229299A1 (en) * 2002-05-21 2004-11-18 Badal M. Youssouf Intracellular complexes as biomarkers
US20040224337A1 (en) * 2003-03-04 2004-11-11 Erik Foehr Use of biomolecular targets in the treatment and visualization of tumors
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US20100137163A1 (en) 2006-01-11 2010-06-03 Link Darren R Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
WO2007133710A2 (en) 2006-05-11 2007-11-22 Raindance Technologies, Inc. Microfluidic devices and methods of use thereof
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP2315629B1 (de) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Tröpfchenbibliotheken
EP2411148B1 (de) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation von mikrofluidiktröpfchen
EP2486409A1 (de) 2009-10-09 2012-08-15 Universite De Strasbourg Markiertes nanomaterial auf siliziumbasis mit verbesserten eigenschaften und seine verwendung
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
CN102108365A (zh) * 2009-12-29 2011-06-29 上海新号源生物科技有限公司 一组恶性肿瘤中突变PTPα基因及其应用
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US8535889B2 (en) 2010-02-12 2013-09-17 Raindance Technologies, Inc. Digital analyte analysis
EP3447155A1 (de) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwichassays in tröpfchen
EP3859011A1 (de) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Verfahren zur bildung gemischter tröpfchen
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3216872B1 (de) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Enzymquantifizierung
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN112837815A (zh) * 2021-02-04 2021-05-25 复旦大学附属中山医院 基于Lauren分型和术后残留淋巴结评估胃癌预后的模型及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538886A (en) * 1990-07-11 1996-07-23 New York University Receptor-type phosphotyrosine phosphatase-alpha
GB9214754D0 (en) * 1992-07-10 1992-08-19 Univ Singapore Tumour treatment

Also Published As

Publication number Publication date
AU2738195A (en) 1996-01-05
EP0764272B1 (de) 2001-01-03
DE69519796T2 (de) 2001-04-19
EP0764272A1 (de) 1997-03-26
ATE198513T1 (de) 2001-01-15
WO1995034818A1 (en) 1995-12-21
US5888746A (en) 1999-03-30
GB9411671D0 (en) 1994-08-03

Similar Documents

Publication Publication Date Title
DE69519796D1 (de) PTPalpha-Bestimmung in der Tumordiagnose und -Prognose
Schwartz Keratoacanthoma: a clinico‐pathologic enigma
Barnekow et al. Expression of the c-src protooncogene in human skin tumors
WO1998035985B1 (en) Protein markers for lung cancer and use thereof
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
TR199902828T2 (xx) Lizofosfolipidlerin de�i�mi� konsantrasyonlar� ile birle�tirilmi� kanser belirleme y�ntemi.
Weickmann et al. Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer
ATE175996T1 (de) Diagnose von krebs, dessen zellen das am tyrosin phosphorylierte crkl-protein exprimieren
PT922223E (pt) Metodo para o diagnostico do cancro da prostata
ATE168472T1 (de) Nachweis von prostat-spezifischen antigen in brusttumoren
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
BR9914161A (pt) Métodos para detectar a presença de células de câncer de mama e de células de câncer endometrial e a presença de câncer de mama e de câncer endometrial em um paciente e kits para detectar a presença de células de neoplasia de mama e a presença de câncer de mama em uma amostra
FR2780791B1 (fr) Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
Bhatavdekar et al. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer
AU3485393A (en) Immunological method for the detection of malignant tumours, and a kit for carrying out the method
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
Zoll et al. Alterations of the c-erbB2 gene in human breast cancer
Nagai et al. Expression of autocrine motility factor receptor in cutaneous malignant melanoma
BR9611255A (pt) ácido nucleico, processos para determinar a suscetibilidade de um paciente a câncer, para diagnosticar câncer em um paciente, para prever as perspectivas relativas do surgimento particular de um câncer em um paciente, para tratar câncer e para determinar a perda de heterozigosidade em amostra de tecido, sistema para detectar a presença ou ausência de, ou mutação, na região de cromossomo 10 humano, polipeptídeo, molécula e uso de ácido nucleico e de uma molécula.
DE69637123D1 (de) Die expression von cyclin g1 in tumoren
ES2151665T3 (es) Procedimiento y equipo para predecir la respuesta terapeutica de un farmaco contra un tumor maligno.
Motomiya et al. Studies on urinary isozymes of lactic dehydrogenase and β-glucuronidase in patients with bladder tumors
Carrillo et al. Reverse transcriptase–polymerase chain reaction detection of circulating tumor cells in patients with melanoma: Correlation with clinical stage, tumor thickness and histological type
Prasad et al. Isozyme variations in human malignant melanoma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee